Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.

BACKGROUND AND OBJECTIVE: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were al...

Full description

Bibliographic Details
Main Authors: Lei Liu, Zhiwei Wang, Songqi Jiang, Bingfeng Shao, Jibing Liu, Suqing Zhang, Yilong Zhou, Yuan Zhou, Yixin Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3669337?pdf=render
_version_ 1828756957313368064
author Lei Liu
Zhiwei Wang
Songqi Jiang
Bingfeng Shao
Jibing Liu
Suqing Zhang
Yilong Zhou
Yuan Zhou
Yixin Zhang
author_facet Lei Liu
Zhiwei Wang
Songqi Jiang
Bingfeng Shao
Jibing Liu
Suqing Zhang
Yilong Zhou
Yuan Zhou
Yixin Zhang
author_sort Lei Liu
collection DOAJ
description BACKGROUND AND OBJECTIVE: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were all-cause death, tumor recurrence and postoperative complications. METHODS: Relevant articles were identified through MEDLINE search (up to November 2012). Meta-analyses were performed by using the fixed or random effect models. Study heterogeneity was assessed by Q-test and I(2) test. Publication bias was evaluated by funnel plots, Egger's and Begg's test. RESULTS: A total of 5635 cases from 22 studies finally met our inclusion criteria. Meta-analysis indicated HCC patients with ABT had an increased risk of all-cause death at 3 and 5 years after surgery (respectively: OR = 1.92, 95% CI, 1.61-2.29,P<0.001; OR = 1.60, 95% CI, 1.47-1.73,P<0.001 ) compared with those without ABT. The risk of tumor recurrence was significantly higher for ABT cases at 1, 3 and 5 years (respectively: OR = 1.70, 95% CI, 1.38-2.10, P<0.001; OR = 1.22, 95% CI, 1.08-1.38, P<0.001; OR = 1.16, 95% CI, 1.08-1.24, P<0.001). The HCC cases with ABT significantly increased postoperative complications occurrence compared with non-ABT cases (OR = 1.78,95% CI, 1.34-2.37, P<0.001). CONCLUSIONS: The findings from the current meta-analysis demonstrated that ABT was associated with adverse clinical outcomes for HCC patients undergoing surgery, including increased death, recurrence and complications. Therefore, ABT should not be performed if possible.
first_indexed 2024-12-10T23:25:23Z
format Article
id doaj.art-b7f0164118ff483bae0613c7a9577031
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T23:25:23Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b7f0164118ff483bae0613c7a95770312022-12-22T01:29:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6426110.1371/journal.pone.0064261Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.Lei LiuZhiwei WangSongqi JiangBingfeng ShaoJibing LiuSuqing ZhangYilong ZhouYuan ZhouYixin ZhangBACKGROUND AND OBJECTIVE: The impact of perioperative allogenenic blood transfusion (ABT) on clinical outcomes for hepatocellular carcinoma (HCC) is conflicting and unclear. The aim of this meta-analysis is to evaluate the association between ABT and HCC clinical outcomes. Outcomes evaluated were all-cause death, tumor recurrence and postoperative complications. METHODS: Relevant articles were identified through MEDLINE search (up to November 2012). Meta-analyses were performed by using the fixed or random effect models. Study heterogeneity was assessed by Q-test and I(2) test. Publication bias was evaluated by funnel plots, Egger's and Begg's test. RESULTS: A total of 5635 cases from 22 studies finally met our inclusion criteria. Meta-analysis indicated HCC patients with ABT had an increased risk of all-cause death at 3 and 5 years after surgery (respectively: OR = 1.92, 95% CI, 1.61-2.29,P<0.001; OR = 1.60, 95% CI, 1.47-1.73,P<0.001 ) compared with those without ABT. The risk of tumor recurrence was significantly higher for ABT cases at 1, 3 and 5 years (respectively: OR = 1.70, 95% CI, 1.38-2.10, P<0.001; OR = 1.22, 95% CI, 1.08-1.38, P<0.001; OR = 1.16, 95% CI, 1.08-1.24, P<0.001). The HCC cases with ABT significantly increased postoperative complications occurrence compared with non-ABT cases (OR = 1.78,95% CI, 1.34-2.37, P<0.001). CONCLUSIONS: The findings from the current meta-analysis demonstrated that ABT was associated with adverse clinical outcomes for HCC patients undergoing surgery, including increased death, recurrence and complications. Therefore, ABT should not be performed if possible.http://europepmc.org/articles/PMC3669337?pdf=render
spellingShingle Lei Liu
Zhiwei Wang
Songqi Jiang
Bingfeng Shao
Jibing Liu
Suqing Zhang
Yilong Zhou
Yuan Zhou
Yixin Zhang
Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
PLoS ONE
title Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
title_full Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
title_fullStr Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
title_full_unstemmed Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
title_short Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.
title_sort perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma a meta analysis
url http://europepmc.org/articles/PMC3669337?pdf=render
work_keys_str_mv AT leiliu perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT zhiweiwang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT songqijiang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT bingfengshao perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT jibingliu perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT suqingzhang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT yilongzhou perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT yuanzhou perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis
AT yixinzhang perioperativeallogenenicbloodtransfusionisassociatedwithworseclinicaloutcomesforhepatocellularcarcinomaametaanalysis